series-c-plus
Stage
3
Investors
About
Egalet is a specialty pharmaceutical company that develops and manufactures pain medicines with proprietary abuse-deterrent technology to reduce prescription opioid abuse and improve patient safety.
Explore Egalet's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.